BACKGROUND AND OBJECTIVE: Methodological variability in the assessment of white matter hyperintensities (WMH) in dementia may explain inconsistent reports of its prevalence and impact on cognition. We used a method of brain MRI segmentation for quantifying both tissue and WMH volumes in Alzheimer's disease (AD) and examined the association between WMH and structural and cognitive variables. METHODS: A consecutive series of 81 patients meeting NINCDS-ADRDA criteria for probable AD was studied. Nineteen healthy volunteers of comparable age served as the control group. Patients had a complete neurological and neuropsychological evaluation, and a three dimensional MRI was obtained. Images were segmented into grey matter, white matter, and cerebrospinal fluid. WMH were edited on segmented images, and lobar assignments were based on Talairach coordinates. RESULTS: Mild and moderate to severe AD patients had significantly more WMH than controls (p<0.05). WMH preferentially involved the frontal lobes (70%), were inversely correlated with grey matter cortical volume (R(2) = 0.23, p<0.001), and were significantly associated with vascular risk factors and with a worse performance on memory tasks. CONCLUSION: Objective measurements of tissue volumes in AD demonstrated that WMH are significantly related to cortical atrophy and neuropsychological impairment.
BACKGROUND AND OBJECTIVE: Methodological variability in the assessment of white matter hyperintensities (WMH) in dementia may explain inconsistent reports of its prevalence and impact on cognition. We used a method of brain MRI segmentation for quantifying both tissue and WMH volumes in Alzheimer's disease (AD) and examined the association between WMH and structural and cognitive variables. METHODS: A consecutive series of 81 patients meeting NINCDS-ADRDA criteria for probable AD was studied. Nineteen healthy volunteers of comparable age served as the control group. Patients had a complete neurological and neuropsychological evaluation, and a three dimensional MRI was obtained. Images were segmented into grey matter, white matter, and cerebrospinal fluid. WMH were edited on segmented images, and lobar assignments were based on Talairach coordinates. RESULTS: Mild and moderate to severe ADpatients had significantly more WMH than controls (p<0.05). WMH preferentially involved the frontal lobes (70%), were inversely correlated with grey matter cortical volume (R(2) = 0.23, p<0.001), and were significantly associated with vascular risk factors and with a worse performance on memory tasks. CONCLUSION: Objective measurements of tissue volumes in AD demonstrated that WMH are significantly related to cortical atrophy and neuropsychological impairment.
Authors: G Harris; N C Andreasen; T Cizadlo; J M Bailey; H J Bockholt; V A Magnotta; S Arndt Journal: J Comput Assist Tomogr Date: 1999 Jan-Feb Impact factor: 1.826
Authors: F Fazekas; R Kleinert; H Offenbacher; R Schmidt; G Kleinert; F Payer; H Radner; H Lechner Journal: Neurology Date: 1993-09 Impact factor: 9.910
Authors: N C Andreasen; R Rajarethinam; T Cizadlo; S Arndt; V W Swayze; L A Flashman; D S O'Leary; J C Ehrhardt; W T Yuh Journal: J Comput Assist Tomogr Date: 1996 Jan-Feb Impact factor: 1.826
Authors: C DeCarli; D G Murphy; M Tranh; C L Grady; J V Haxby; J A Gillette; J A Salerno; A Gonzales-Aviles; B Horwitz; S I Rapoport Journal: Neurology Date: 1995-11 Impact factor: 9.910
Authors: S E Starkstein; L Sabe; S Vazquez; A Teson; G Petracca; E Chemerinski; G Di Lorenzo; R Leiguarda Journal: Stroke Date: 1996-03 Impact factor: 7.914
Authors: Christina K Cramer; Tiffany L Cummings; Rachel N Andrews; Roy Strowd; Stephen R Rapp; Edward G Shaw; Michael D Chan; Glenn J Lesser Journal: Curr Treat Options Oncol Date: 2019-04-08
Authors: Adam M Brickman; Laura B Zahodne; Vanessa A Guzman; Atul Narkhede; Irene B Meier; Erica Y Griffith; Frank A Provenzano; Nicole Schupf; Jennifer J Manly; Yaakov Stern; José A Luchsinger; Richard Mayeux Journal: Neurobiol Aging Date: 2014-07-21 Impact factor: 4.673
Authors: M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas Journal: J Nutr Health Aging Date: 2008-12 Impact factor: 4.075
Authors: Catherine C Price; Kelly Davis Garrett; Angela L Jefferson; Stephanie Cosentino; Jared J Tanner; Dana L Penney; Rodney Swenson; Tania Giovannetti; Brianne Magouirk Bettcher; David J Libon Journal: Clin Neuropsychol Date: 2009-08 Impact factor: 3.535
Authors: T M Polvikoski; E C W van Straaten; F Barkhof; R Sulkava; H J Aronen; L Niinistö; M Oinas; P Scheltens; T Erkinjuntti; R N Kalaria Journal: Neurology Date: 2010-11-03 Impact factor: 9.910
Authors: Walter Swardfager; Hugo Cogo-Moreira; Mario Masellis; Joel Ramirez; Nathan Herrmann; Jodi D Edwards; Mahwesh Saleem; Parco Chan; Di Yu; Sean M Nestor; Christopher J M Scott; Melissa F Holmes; Demetrios J Sahlas; Alexander Kiss; Paul I Oh; Stephen C Strother; Fuqiang Gao; Bojana Stefanovic; Julia Keith; Sean Symons; Richard H Swartz; Krista L Lanctôt; Donald T Stuss; Sandra E Black Journal: Neurology Date: 2018-01-26 Impact factor: 9.910
Authors: Meryl A Butters; Jeffrey B Young; Oscar Lopez; Howard J Aizenstein; Benoit H Mulsant; Charles F Reynolds; Steven T DeKosky; James T Becker Journal: Dialogues Clin Neurosci Date: 2008 Impact factor: 5.986